3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered) - Immunogenicity, Safety | Phase 3 | Completed | PT Bio Farma | 220 | 2020-10-13 | 2022-01-18 |
| Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III) Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi Polysaccharide Vaccine - Safety Issues, Immunogenicity | Phase 3 | Completed | PT Bio Farma | 3071 | 2020-03-02 | 2022-01-04 |
| Protectivity and Safety Following Recombinant Hepatitis B Vaccine Recombinant Hepatitis B vaccine, Recombinant Hepatitis B (Bio Farma) - Immunogenicity | Phase 2 / Phase 3 | Completed | PT Bio Farma | 536 | 2019-09-11 | 2022-09-19 |
Hepatitis B Vaccines (1) · Vi polysaccharide vaccine, typhoid (1)
PT Bio Farma (3)
Indonesia (3)
Bernie E Medise, MD (1) · Eddy Fadliyana (1) · Yetty M Nency, MD (1)